TY - JOUR
T1 - Expression of mutant H-2(d) proteins encoded by class I genes which alternatively process the 5' end of their transcripts
AU - Hedley, M. L.
AU - Ozato, K.
AU - Maryanski, J.
AU - Tucker, P. W.
AU - Forman, J.
N1 - Funding Information:
Acknowledgments We thank the staff of PATH Foundation NY. The writing of this article was funded in part by LifeGen, Inc., San Diego, CA, USA. Other support came from NIAAA grants R01-AA07112 and K05-AA00219 and the Medical Research Service of the US Department of Veterans Affairs (to MO-B).
PY - 1989
Y1 - 1989
N2 - Mutation of the 3' splice sites bordering exon 2 of the H-2D(d) and H-2K(d) genes generated alternatively spliced transcripts when the constructs were transfected into L cells (J. Immunol. 143:1018). The H-2D(d) transcripts contained an additional 84 nucleotides derived from the first intervening sequence, whereas 60 extra bases were included in the H-2K(d) mRNA. Proteins derived from these transcripts were recognized by mAb. Moreover, both Ag served as recognition elements for CTL, and the mutant H-2K(d) molecule functioned as a restricting element for an Ag peptide. As a result of alternative splicing, the mutant proteins should have additional residues at their NH2 termini to increase their lengths by 28 (D(d)) or 20 (K(d)) amino acids. Immunoprecipitation and analysis on SDS-PAGE demonstrated that the mutant H-2K(d) molecule was indeed larger than the normal H-2K(d) protein, but the mutant and wild-type H-2D(d) Ag were the same size. In addition, treatment of H-2D(d) mutant and normal Ag with N-glycanase produced molecules of equal size, demonstrating that the mutant protein was completely glycosylated. Limited amino acid sequencing of this Ag indicated that it was normal H-2D(d). Therefore, before its transfer to the cell surface, post-translational modifications remove the additional NH2-terminal residues of the mutant D(d) but not K(d) protein.
AB - Mutation of the 3' splice sites bordering exon 2 of the H-2D(d) and H-2K(d) genes generated alternatively spliced transcripts when the constructs were transfected into L cells (J. Immunol. 143:1018). The H-2D(d) transcripts contained an additional 84 nucleotides derived from the first intervening sequence, whereas 60 extra bases were included in the H-2K(d) mRNA. Proteins derived from these transcripts were recognized by mAb. Moreover, both Ag served as recognition elements for CTL, and the mutant H-2K(d) molecule functioned as a restricting element for an Ag peptide. As a result of alternative splicing, the mutant proteins should have additional residues at their NH2 termini to increase their lengths by 28 (D(d)) or 20 (K(d)) amino acids. Immunoprecipitation and analysis on SDS-PAGE demonstrated that the mutant H-2K(d) molecule was indeed larger than the normal H-2K(d) protein, but the mutant and wild-type H-2D(d) Ag were the same size. In addition, treatment of H-2D(d) mutant and normal Ag with N-glycanase produced molecules of equal size, demonstrating that the mutant protein was completely glycosylated. Limited amino acid sequencing of this Ag indicated that it was normal H-2D(d). Therefore, before its transfer to the cell surface, post-translational modifications remove the additional NH2-terminal residues of the mutant D(d) but not K(d) protein.
UR - http://www.scopus.com/inward/record.url?scp=0024413971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024413971&partnerID=8YFLogxK
M3 - Article
C2 - 2473108
AN - SCOPUS:0024413971
SN - 0022-1767
VL - 143
SP - 1026
EP - 1031
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -